
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 131.740 | 132.110 | 0.370 |
Bonds | 4.570 | 4.570 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 18.129 | 15.206 |
Price to Book | 3.092 | 2.007 |
Price to Sales | 2.220 | 1.363 |
Price to Cash Flow | 14.364 | 9.082 |
Dividend Yield | 2.384 | 3.218 |
5 Years Earnings Growth | 8.644 | 10.473 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 20.100 | 13.241 |
Consumer Cyclical | 16.650 | 12.340 |
Basic Materials | 14.480 | 8.478 |
Consumer Defensive | 12.740 | 8.679 |
Financial Services | 11.130 | 15.463 |
Technology | 10.040 | 11.528 |
Communication Services | 9.040 | 7.328 |
Industrials | 4.520 | 21.200 |
Utilities | 1.310 | 3.242 |
Number of long holdings: 62
Number of short holdings: 5
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Amundi | FR0004125920 | 9.18 | 65.15 | -0.15% | |
Elis Sa (Fp*)- Cfd | - | 6.42 | - | - | |
Eurofins Scientific | FR0014000MR3 | 5.76 | 67.34 | -0.47% | |
Hermes International | FR0000052292 | 5.08 | 2,073.00 | +0.39% | |
Roche Holding Participation | CH0012032048 | 4.78 | 256.00 | 0.00% | |
Nestle | CH0038863350 | 4.73 | 72.21 | -0.18% | |
Stroeer | DE0007493991 | 4.66 | 42.100 | -1.98% | |
L'Oreal | FR0000120321 | 4.60 | 393.30 | +0.10% | |
BKO 2 12/10/26 Corp | - | 4.57 | - | - | |
Ferrari NV | NL0011585146 | 4.52 | 462.65 | +0.46% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1371438018 | 20.13M | 3.83 | - | - | ||
LU1371437127 | 1.4M | -3.35 | -0.78 | - | ||
LU1371436152 | 1.4M | -3.34 | - | - | ||
LU1842610906 | 1.4M | -3.83 | -2.20 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review